ro13-9904 and Mouth-Diseases

ro13-9904 has been researched along with Mouth-Diseases* in 3 studies

Reviews

1 review(s) available for ro13-9904 and Mouth-Diseases

ArticleYear
Neisseria gonorrhoeae in children.
    Pediatric annals, 1994, Volume: 23, Issue:7

    By culturing for N gonorrhoeae in cases of neonates and children with conjunctivitis, vaginitis, urethritis, proctitis, sepsis, and arthritis, gonococcal infections can be identified easily. They are then treated with ceftriaxone. In neonates, the mother and her sexual contacts also should be treated. In children, a full evaluation for sexual contacts, with the assistance of other professionals, if necessary, will almost always identify a sexual contact. Appropriate action then can be taken to protect the child from further sexual contact. .

    Topics: Abscess; Ceftriaxone; Child; Child, Preschool; Conjunctivitis; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Mouth Diseases; Ophthalmia Neonatorum; Pelvic Inflammatory Disease; Pharyngeal Diseases; Proctitis; Scalp Dermatoses; Urethritis; Vaginitis

1994

Other Studies

2 other study(ies) available for ro13-9904 and Mouth-Diseases

ArticleYear
[Clinical effect of ceftriaxone and cefditoren administration against oral and genital gonococcal infection].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1

    The clinical findings of genococcal infection (oral and genital) and the clinical effect of ceftiaxone (CTRX) and cefditoren (CDTR) administration were studied in Commercial Sex Workers (CSW). The gonococci were detected by DNA probe method (mouth), PCR method (genitals) and ELISA method (chlamydial antibody detection). 1) In the oral infection group (n = 20), chlamydial infection (65%), herpes infection (25%), and genital gonococcal infection (35%) were noted. Pharyngeal pain was observed in 9 out of 9 patients with tonsillitis and 4 out of 11 patients with pharyngitis. High fever and cervical lymphadenopathy were observed in 3 out of 9 patients with tonsillitis. 40% (8/20) of the partners had infections. Both CTRX administration (1 - 2 g/day x 3 days) (n = 11) and consecutive administration of CDTR (300 mg/day x 3 - 7 days) following CTRX administration (1 - 2 g/days x 1 - 3 days) (n = 9) were effective in all patients. 2) In the genital infection group (n = 35), chlamydial infection (65.7%), herpes infection (25.7%) and oral gonococcal infection (17.1%) were observed in 3 out of 6 patients with tonsillitis and 3 out of 6 patients with pharyngitis. The treatment was effective in all patients in the CTRX (1 - 2 g/day x 2 - 3 days) group (n = 14), CDTR (300 mg/day x 5 - 7 days) group (n = 5) and consecutive administration of CDTR (300 mg/day x 3 - 7 days) after CTRX (1 - 2 g/day x 1 - 3 days) and (n = 14). In pelvic peritonitis (n = 2), CTRX administration (2 - 4 g/day x 3 - 7 days) were effective.

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Female; Gonorrhea; Humans; Mouth Diseases; Sex Work

2006
[Clinico-statistical observations on the use of ceftriaxone (rocefin) in dental practice and maxillofacial surgery].
    Minerva stomatologica, 1987, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ketoprofen; Male; Middle Aged; Mouth Diseases; Piperacillin; Surgery, Oral

1987